Journal of Clinical and Experimental Hematopathology
Online ISSN : 1880-9952
Print ISSN : 1346-4280
ISSN-L : 1346-4280
Tolerogen-Producing Cells in Allogeneic Bone Marrow Chimeras Established with Spontaneously Leukemia-Prone Mice
Machiko MishimaMari HiranoTaiki MorohashiNoriko AraseHayase ShisaHiroshi HiaiManabu AtoKazunori Onoé
著者情報
ジャーナル フリー

2001 年 41 巻 1 号 p. 61-68

詳細
抄録
Using SL/Kh mice and AKR/J mice, which are animal models for spontaneous pre-B-cell leukemia and thymic lymphoma, respectively, we studied the protective influence of allogeneic bone marrow transplantation (BMT) and the induction of tolerance to Mls-1a, a host antigen. When BM cells from allogeneic C57BL/6 mice were used to reconstitute self-tolerance SL/Kh mice, these [B6→SL] chimeric mice survived for a longer time than non-treated SL or [SL→SL] syngeneic chimeras. These findings are compatible with results previously obtained for [B6→AKR] chimeras. In [B10. D2→SL] and [B10. D2→AKR] chimeras, Vβ6+ T-cells reactive to Mls-1a were eliminated 5 weeks after BMT. On the other hand, minor graft versus host reaction (GVHR) abrogated the clonal elimination of Vβ6+ T-cells in both [B10. D2→SL] and [B10. D2→AKR] chimeras. The cause of this abrogation was attributed to the early disappearance of Mls-1a-producing host T-cells in the GVHR chimeras. The cells responsible for the Mls-1a production were revealed to be mainly CD8+ CD44+ T-cells, by in vitro mixed lymphocyte reaction (MLR) and in vivo tolerance induction. The present findings indicate that host CD8+ CD44+ T-cells constitute the major source of Mls-1a antigens in the [Mls-1b→Mls-1a] BM chimera system.
引用文献 (38)
  • 1 Reinisch CL, Litman GW: Evolutionary immunobiology. Immunol Today 10: 278-281, 1989

  • 2 MacDonald HR, Schneider R, Lees RK, Howe RC, Acha-Orbea H, Festenstein H, Zinkernagel RM, Hengartner H: T-cell receptor Vb use predicts reactivity and tolerance to Mlsa-encoded antigen. Nature 332: 40-45, 1988

  • 3 Abe R, Hodes RJ: T-cell recognition of minor lymphocyte stimulating (Mls) gene products. Annu Rev Immunol 7: 683-708, 1989

  • 4 Herman A, Kappler JW, Marrack P, Pullen AM: Superantigens: mechanism of T-cell stimulation and role in immune responses. Annu Rev Immunol 9: 745-772, 1991

  • 5 Janeway CA Jr: Selective elements for the Vb region of the T-cell receptor: Mls and the bacterial toxic mitogenes. Adv Immunol 50: 1-53, 1991

  • 6 Marrack P, Kushnir E, Kappler J: A maternally inherited superantigen encoded by a mammary tumor virus. Nature 349: 524-526, 1991

  • 7 Fukushi N, Wang B, Arase H, Ogasawara K, Good RA, Ono K: Cell components required for deletion of an auto-reactive T-cell repertoire. Eur J Immunol 20: 1153-1160, 1990

  • 8 Arase H, Arase N, Ogasawaea K, Good RA, Ono K: Clonal elimination of self reactive Vb6+ T-cells induced by H-2 products expressed on thymic radio-resistant components. Int Immunol 4: 75-82, 1992

  • 9 Speiser DE, Chvatchko Y, Zinkernagel RM, MacDonald HR: Distinct fate of self-specific T-cells developing in irradiation bone marrow chimeras: clonal deletion, clonal anergy, or in vitro responsiveness to self-Mls-1a controlled by hemopoietic cells in the thymuses. J Exp Med 172: 1305-1314, 1990

  • 10 Yoshikai Y, Ogimoto M, Matsumoto K, Sakumoto M, Matsuzaki G, Nomoto K: Deletion of Mls-reactive T-cells in H-2 compatible but Mls-incompatible bone marrow chimeras. Eur J immunol 19: 1009-1013, 1989

  • 11 Arase-Fukushi N, Arase H, Wang B, Ogasawara K, Good RA, Ono K: Production of minor lymphocyte stimulatory-1a antigen from activated CD4+ or CD8+ T-cells. J Immunol 151: 4445-4454, 1993

  • 12 Fukushi N, Arase H, Wang B, Ogasawara K, Gotohda T, Good RA, Ono K: Thymus, a direct target tissue in graft versus host reaction after allogeneic bone marrow transplantation which results in abrogation of induction of self-tolerance. Proc Natl Acad Sci USA 87: 6301-6305, 1990

  • 13 Ono K, Fernandes G, Good RA: Humoral and cell-mediated immune responses in fully allogeneic bone marrow chimera in mice. J Exp Med 151: 115-132, 1980

  • 14 Ono K, Yasumizu R, Oh-ishi T, Kakinuma M, Good RA, Fernandes G, Morikawa K: Specific elimination of the T lineage cells: Effect of in vitro treatment with anti-Thy-1 serum without complement on the adoptive cell transfer system. J Immunol Methods 49: 315-322, 1982

  • 15 Arase-Fukushi N, Arase H, Wang B, Hirano M, Ogasawara K, Good RA, Ono K: Influence of a small number of mature T-cells in donor bone marrow inocula on reconstitution of lymphoid tissues and negative selection of a T-cell repertoire in the recipient. Microbiol Immunol 37: 883-894, 1993

  • 16 Arase N, Arase H, Takayanagi T, Mishima M, Iwabuchi K, Ogasawara K, Ono K: Production of minor lymphocyte stimulatory-1a antigens from T-cell subsets. Immunobiol 193: 378-390, 1995

  • 17 Iwabuchi C, Iwabuchi K, Nakagawa K, Takayanagi T, Nishihori H, Tone S, Ogasawara K, Good RA, Ono K: Intrathymic selection of NK1.1+ a/b T-cell antigen receptor (TCR)+ cells in transgenic mice bearing TCR specific for chicken ovalbumin and restricted to I-Ad. Proc Natl Acad Sci USA 95: 8199-8204, 1998

  • 18 Iwabuchi K, Iwabuchi C, Tone S, Itoh D, Tosa N, Negishi I, Ogasawara K, Uede T, Ono K: Defective development of NK1.1+ T-cell antigen receptor (TCR) ab+ cells in zeta-associated protein (ZAP) null mice with an accumulation of NK1.1+ CD3-NK-like cells in the thymus. Blood, (in press)

  • 19 Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanatephenol-chloroform extraction. Anal Biochem 162: 156-159, 1987

  • 20 Sambrook J, Fritsch EF, Maniatis T: In Molecular Cloning: A Laboratory Manual. Vol. 1. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. 1989

  • 21 Shimada MO, Yamada Y, Nakakuki Y, Okamoto K, Fukumoto M, Honjo T, Hiai H: SL/KH strain of mice: a model of spontaneous pre-B-lymphomas. Leukemia Res 17: 573-578, 1993

  • 22 Hiai H, Kaneshima H, Nakamura H, Oguro YB, Moriwaki K, Nishizuka Y: Unusually early and high rate of spontaneous occurrence of nonthymic leukemia in SL/Kh mice, a subline of SL strain. Jpn J Cancer Res 73: 704-712, 1982

  • 23 Aizawa S, Sado T: Graft-versus-leukemia effect in MHC-compatible and incompatible allogeneic bone marrow transplantation of radiation-induced, leukemia-bearing mice. Transplantation 52: 885-889, 1991

  • 24 Tanaka T, Obata Y, Fernandes G, Ono K, Stockert E, Good RA: Prevention of leukemia in lethally irradiated AKR mice by CBA-H marrow transplantation. Proc Am Assoc Cancer Res 20: 114, 1979 (Abstr.).

  • 25 Hirano M, Arase H, Arase-Fukushi N, Ogasawara K, Iwabuchi K, Miyazaki T, Good RA, Ono K: Reconstitution of lymphoid tissues under the influence of subclinical level of graft versus host reaction induced by bone marrow T-cells or splenic T-cell subsets. Cell Immunol 151: 118-132, 1993

  • 26 Ono K, Arase N, Arase H, Takayanagi T, Nishihori H, Iwabuchi K, Ogasawara K, Good RA: Influence of graft versus host reaction on the T-cell repertoire differentiating from bone marrow precursors following allogeneic bone marrow transplantation. Transplant Immunol 5: 75-82, 1997

  • 27 Good RA: Toward safer marrow transplantation. New Eng J Med 306: 421-423, 1982

  • 28 Good RA, Kapoor N, Reisner Y: Bone marrow transplantation-an expanding approach to tretment of many diseases. Cell Immunol 82: 36-54, 1983

  • 29 Sykes M, Sheard MA, Sachs DH: Effects of T-cell depletion in radiation bone marrow chimeras II. Requirement for allogeneic T-cells in the reconstituting bone marrow inoculum for subsequent resistance to breaking tolerance. J Exp Med 168: 661-673, 1988

  • 30 Murphy WJ, Kumar V, Cope JC, Bennett M: An absence of T-cells in murine bone marrow allografts leads to an increased susceptibility to rejection by natural killer cells and T-cells. J Immunol 144: 3305-3311, 1990

  • 31 Horowitz MM, Gale RP, Sondel PM, Goldman JM, Kersey J, Kolb HJ, Rim AA, Ringden O, Rozman C, Speck B: Graft-versus-leukemia reactions after bone marrow transplantation. Blood 75: 555-562, 1990

  • 32 Morohashi T, Ogasawara K, Kitaichi N, Iwabuchi K, Ono K: Abrogation of negative selection by GVHR induced by minor histocompatibility antigens or H-2D antigen alone. Immunobiol 202: 368-379, 2000

  • 33 Desbarats J, Lapp WS: Thymic selection and thymic major histocompatibility complex class II expression are abnormal in mice undergoing graftversus-host reaction. J Exp Med 178: 805-814, 1993

  • 34 Takayanagi T, Nishihori H, Matsuki N, Iwabuchi K, Ogasawara K, Ono K: Effects of non-major histocompatibility antigens on acute graft-versushost reaction after allogeneic bone marrow transplantation. Bone Marrow Transplant 20: 297-304, 1997

  • 35 Morohashi T, Ogasawara K. Kitaichi N, Iwabuchi K, Ono K: Significant MLR but not CTL responses against recipient antigens generated in T-cells from bone marrow chimeras recovered from GVHD. Bone Marrow Transplant 26: 1069-1076, 2000

  • 36 den Haan JMM, Sherman NE, Blokland E, Huczko E, Koning F, Drijfhout JW, Skipper J, Shabonowitz J, Hunt DF, Engelhard VH: Identification of a graft versus host disease-associated human minor histocompatibility antigen. Science 268: 1476-1480, 1995

  • 37 Leibnitz RR, Lipsky PL, Thiele DL: Protection from T helper cell mediated graft-versus-host disease by the presence of an MHC class I alloantigen is associated with perturbation of MHC class II-restricted responses by class I-derived peptide. J Immunol 155: 1784-1795, 1995

  • 38 Ogasawara K, Ono K: MHC binding motifs and design of peptide-based vaccines. Trends Microbiol 1: 276-279, 1993

著者関連情報
© by The Japanese Society for Lymphoreticular Tissue Research
前の記事 次の記事
feedback
Top